Hollander David
Kiora Pharmaceuticals, Inc. · Director
Hollander David is listed in public filings as director. This Hollander David insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Kiora Pharmaceuticals, Inc. (KPRX), and Revance Therapeutics, Inc. - Common Stock (RVNC). Investors use Hollander David's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $59k20k shares | Grant / ExerciseApr 1, 2025 | $58.6K20k shares | $2.93 | -- |
Insider Trades History
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| --95.2k shares | OtherFeb 6, 2025 | Disclosure amount unavailable95.2k shares | -- | -- | |
| $348k95.2k shares | OtherFeb 4, 2025 | $35.5K9.7k shares | $3.65 | -- | |
| $438k104.9k shares | SellNov 18, 2024 | $16.3K3.9k shares | $4.17 | -- | |
| $7.7k1.8k shares | Grant / ExerciseJul 1, 2024 | $7.7K1.8k shares | $4.35 | -- |